Last Updated: 31-07-2025 | Format: PDF | Report ID:20516 | Author: Manisha C
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? |
| $10,100 Million |
| What is the projected market size by 2035? | $27,800 Million |
| What is the market CAGR from 2025 to 2035? | 10.7% |
| Which region dominates the market? | United States (81%) |
| Which product/service type dominates the market? | Synthetic mRNA (34%) |
| Which application leads the market? | Vaccines (37%) |
| Who are the major buyers? | Biopharma/Biotech Companies (48%), Academic & Research Institutes (32%) |
| What are the key market growth drivers? | Advancements in vaccine technologies; Increasing investments in personalized cancer immunotherapies using mRNA platforms |
| What are the major market challenges? | Ensuring long-term stability and effective storage for mRNA vaccines; Regulatory complexity for novel mRNA constructs and delivery systems |
| What is the forecast period? | 2026–2035 |
| Who are the key market players? | Moderna Inc., BioNTech SE, Pfizer Inc., Thermo Fisher Scientific Inc., GSK plc, CureVac AG, TriLink BioTechnologies, Danaher Corporation, Agilent Technologies, New England Biolabs, Merck KGaA, Samsung Biologics, Aldevron (A Danaher Company), Bio-Synthesis Inc., GenScript Biotech |
| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 10100 |
| Regions | North America (United States, Canada, Mexico) |
| Segments | By Type (Synthetic mRNA, Modified mRNA, Unmodified mRNA, Self-amplifying mRNA, Circular mRNA, Purified mRNA), By Application (Vaccines, Cancer Immunotherapy, Protein Replacement Therapy, Gene Editing, Research Applications, Rare Diseases), By Distribution Channels (Direct Sales, Distributors, Online Platforms, Retail Pharmacies, Hospital Pharmacies, Others), By Technology (In vitro Transcription, Enzymatic Synthesis, Lipid Nanoparticle Formulation, Purification Technologies, Polymerase Chain Reaction, Others), By Organization Size (Small, Medium, Large) |
| Players | Moderna Inc., BioNTech SE, Pfizer Inc., Thermo Fisher Scientific Inc., GSK plc, CureVac AG, TriLink BioTechnologies, Danaher Corporation, Agilent Technologies, New England Biolabs, Merck KGaA, Samsung Biologics, Aldevron (A Danaher Company), Bio-Synthesis Inc., GenScript Biotech |
Manisha C
Lead Industry Analyst
Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
Global Active Pharmaceutical Ingredient Market: by Type (Synthetic, Biotech, HPAPI, Highly Potent, Generic, Branded), Application (Cardiology, Oncology, Neurology, Endocrinology, Anti-infectives, Others), Distribution Channels (Direct Sales, Distributors/Wholesalers, E-commerce, Specialty Pharmacies, Hospitals, Retail Pharmacies), Technology (Traditional, Biotechnology, Fermentation, Chemical Synthesis, High-Throughput Screening, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Microcarriers Market: by Type (Microcarriers Beads, Magnetic Microcarriers, Collagen-based Microcarriers, Synthetic Polymer-based Microcarriers, DEAE-Dextran Based Microcarriers, Others), Application (Cell Therapy, Vaccine Manufacturing, Tissue Engineering, Biologics Production, Drug Development, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail Pharmacies, Specialty Stores, Others), Technology (Surface-modified Microcarriers, Porous Microcarriers, Biodegradable Microcarriers, Injectable Microcarriers, Composite Microcarriers, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Oligonucleotide CDMO Market: by Type (Custom Oligonucleotides, Pre-designed Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Modified Oligonucleotides, Others), Application (Diagnostics, Research, Therapeutics, Forensics, Others), Distribution Channels (Direct Tender, Online Sales, Distributors, Retail Sales, Others), Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis, PCR-based Synthesis, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Whole Exome Sequencing Market: by Type (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), Application (Diagnostics, Drug Discovery, Personalized Medicine, Agriculture & Animal Research, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors, Others), Technology (Next-Generation Sequencing, Sanger Sequencing, Nanopore Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025